Physician profile

Kyle Minkel

Mammoth Lakes, CA

NPI 1073142501

$21,253.36

in general payments reported to CMS, 2019-2025

6 companies · $21K in 2025

The $21K reported for 2025 was more than what 99% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Grant$20,000.00
Food and Beverage$683.50
Education$315.99
Travel and Lodging$153.88

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Arthrex, INC. $20,000.00 2025
Stryker Corporation $529.34 2023-2025 T2 Alpha, Pelvis II, T2
Medical Device Business Services, INC. $315.99 2024
Medacta USA, INC. $294.41 2025 Gmk Sphere
Steelhead Surgical INC $99.99 2022
Depuy Synthes Sales INC. $13.63 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Kyle Minkel

$21,253.36

in general payments reported 2019-2025

Years
2022-2025
Top company
Arthrex, INC.
Context
The $21K reported for 2025 was more than what 99% of providers received nationally.

https://glasscript.com/doctor/11425275/kyle-minkel

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.